Comparison

GLP-1 coverage in Wisconsin

Medicaid does cover GLP-1s for obesity here. What that means, the indications that are still mandatory, and what it costs if you pay cash.

Simplified illustrated map of the United States

Updated 2026-09-18


Medicaid coverage of GLP-1s for obesity is optional for states under a long-standing statutory exception. Wisconsin has exercised that discretion in a specific way.

Wisconsin Medicaid covers GLP-1s for obesity treatment.

Wisconsin is among the states KFF lists as covering GLP-1s for obesity, and has appeared on coverage summaries consistently since at least 2023. Everything below is sourced — we are not going to tell you what a Wisconsin clinic charges, because every provider we track is 50-state telehealth and prices the same wherever you live. What actually differs by state is coverage, and that is what this page is about.

Why Wisconsin is different

Wisconsin is another Midwest state maintaining coverage in the region with the highest adult obesity prevalence nationally. Together with Minnesota and Michigan it means a contiguous block of the upper Midwest has kept coverage while the Northeast has been cutting it.

Medicaid and GLP-1s in Wisconsin

Coverage for obesity is optional for states — the national picture is on our coverage index. Here is where Wisconsin sits.

Wisconsin
StatusMedicaid does cover GLP-1s for obesity here
RegionMidwest — regional adult obesity prevalence 35.9%
Board of pharmacyWisconsin Pharmacy Examining Board

If you are on Medicaid in Wisconsin

What to do in Wisconsin: Confirm the prior-authorisation criteria before applying, and ask whether any eligibility threshold applies — Michigan next door narrowed its threshold rather than cutting coverage, and that pattern can spread.

Coverage for type 2 diabetes, cardiovascular disease and sleep apnea is mandatory everywhere, so a refusal framed around weight loss is not the end of it — and on Medicare, the $50 programme starts 1 July 2026 regardless of which state you are in.

Read next

  • Medicare, GLP-1s and the $50 month

    CMS is running a time-limited programme giving eligible Part D members certain GLP-1s for $50 a month. If you are on Medicare, read this before paying cash for anything.

  • Who names their pharmacy

    The hardest fact to get out of this market, and the one the FDA’s enforcement actually turns on. Here is who publishes it.

  • Providers that work your insurance

    Prior authorisations, appeals and coverage checks. For anyone whose plan might say yes, this is worth more than any discount.

  • Trimi tirzepatide review

    Lowest flat price with named pharmacies. What is actually dispensed, how the prescription works, and what the price really is — $125 a month.

Coreage Rx pays us a commission on sign-ups through our links. It does not affect our scores or rankings. How we rate · Disclosure